This post is from a suggested group
Mechanism of Action and Clinical Pharmacology of Modern Antihistamine Drugs
Antihistamines are pharmacologic agents designed to inhibit the effects of histamine, a key mediator in allergic and inflammatory responses.
Histamine exerts its effects through four primary receptors (H1 through H4). In 2026, clinical focus is primarily on H1-receptor antagonists for allergy management and H2-receptor antagonists for gastric acid regulation.
The distinction between "First-Generation" and "Second-Generation" H1 antihistamines remains a vital clinical consideration. First-generation agents (e.g., diphenhydramine) are lipophilic and cross the blood-brain barrier, leading to significant sedation and anticholinergic effects. Second-generation agents (e.g., loratadine, cetirizine) are engineered to be more peripherally selective, providing symptom relief without the central nervous system impairment. These drugs are essential for treating allergic rhinitis, urticaria, and angioedema, with 2026 formulations offering faster onset and longer durations of action.